Skip to main navigation Skip to search Skip to main content

Antibody–Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling

  • Ankita P. Sankar
  • , Hyun Mi Cho
  • , Seung Uon Shin
  • , Tal Sneh
  • , Sundaram Ramakrishnan
  • , Christian Elledge
  • , Yu Zhang
  • , Rathin Das
  • , Hava Gil-Henn
  • , Joseph D. Rosenblatt
  • University of Miami
  • Bar-Ilan University
  • Inc.

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Antibody–Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science